Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Persistence Market Research | PRODUCT CODE: 1926327

Cover Image

PUBLISHER: Persistence Market Research | PRODUCT CODE: 1926327

Anti-Embolism Stockings Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2048

PUBLISHED:
PAGES: 250 Pages
DELIVERY TIME: 2-5 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4995
PDF & Excel (Multi User License)
USD 7295
PDF & Excel (Corporate User License)
USD 8495

Add to Cart

Persistence Market Research has recently released a comprehensive report on the worldwide market for anti-embolism stockings. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global anti-embolism stockings market from 2025 to 2032. The anti-embolism stockings market is positioned for significant growth, with a projected CAGR of 5.2% from 2025 to 2032, indicating a market value increase from USD 783.6 million in 2025 to USD 1,117.40 million by 2032.

Key Insights:

  • Anti-Embolism Stockings Market Size (2025E): USD 783.6 Mn
  • Projected Market Value (2032F): USD 1,117.40 Mn
  • Global Market Growth Rate (CAGR 2025 to 2032): 5.2%.

Anti-Embolism Stockings Market - Report Scope:

Anti-embolism stockings play a crucial role in preventing deep vein thrombosis (DVT) and pulmonary embolism, especially among bedridden and post-surgical patients. These medical compression garments improve blood circulation in the legs by applying graduated pressure, reducing the risk of clot formation during prolonged immobility. The anti-embolism stockings market caters to hospitals, clinics, surgical centers, and homecare environments, offering a variety of stocking types, including knee-length, thigh-length, and full-length variants. Market growth is supported by increasing surgical procedures worldwide, rising incidence of venous disorders, and growing awareness of preventive healthcare solutions. Technological improvements in fabric materials and comfort-focused designs further enhance patient compliance and adoption.

Market Growth Drivers:

The global anti-embolism stockings market is propelled by several key factors, including the rising prevalence of cardiovascular diseases and venous thromboembolism cases globally. The increasing number of surgeries, particularly orthopedic and abdominal procedures requiring prolonged bed rest, drives strong demand for preventive compression solutions. Aging populations, who are more susceptible to circulation-related disorders, also contribute to market expansion. Additionally, growing hospital protocols emphasizing preventive care and patient recovery outcomes boost adoption rates. Improved product designs offering enhanced comfort, breathability, and durability further stimulate market growth by improving patient adherence to compression therapy.

Market Restraints:

Despite promising growth prospects, the anti-embolism stockings market faces challenges related to patient discomfort, improper usage, and lack of awareness in developing regions. Some patients experience difficulty wearing compression garments correctly, limiting treatment effectiveness. Price sensitivity in emerging economies and limited reimbursement coverage for preventive medical products also restrain adoption rates. Furthermore, the availability of alternative DVT prevention methods, such as anticoagulant drugs and intermittent pneumatic compression devices, may reduce dependence on stockings in certain healthcare settings. Addressing these barriers requires enhanced patient education and affordable product offerings.

Market Opportunities:

The anti-embolism stockings market presents significant growth opportunities driven by innovations in textile technology, expansion of home healthcare services, and increased focus on outpatient surgical recovery. Rising adoption of homecare treatments encourages demand for easy-to-use and comfortable compression garments. Additionally, emerging markets with expanding healthcare infrastructure provide untapped opportunities for manufacturers. Digital healthcare platforms and telemedicine services further enable monitoring and guidance for patients using compression therapy at home. Investment in ergonomic product designs and antimicrobial materials is expected to create new competitive advantages and stimulate long-term market growth.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the anti-embolism stockings market globally?
  • Which product types and applications are driving adoption across healthcare settings?
  • How are technological advancements reshaping product innovation and competitive positioning?
  • Who are the key players contributing to the anti-embolism stockings market, and what strategies are they using to maintain market leadership?
  • What emerging trends and future prospects are shaping the global anti-embolism stockings market?

Competitive Intelligence and Business Strategy:

Leading players in the global anti-embolism stockings market, including 3M Company, Medtronic plc, and Cardinal Health, focus on product innovation, distribution expansion, and strategic collaborations to strengthen their market position. Companies invest heavily in R&D to introduce breathable, latex-free, and patient-friendly compression garments that improve comfort and treatment compliance. Partnerships with hospitals, healthcare distributors, and homecare service providers facilitate broader product reach. Additionally, companies are expanding into emerging markets through local partnerships and cost-effective product lines to capture untapped patient populations.

Key Companies Profiled:

  • MD
  • Medtronic(Covidien)
  • Sigvaris, Medi
  • BSN Medical
  • Juzo
  • 3M
  • Bauerfeind AG
  • Thuasne Corporate
  • Pretty Legs Hosiery
  • Salzmann-Group
  • Paul Hartmann
  • Cizeta Medicali
  • Belsana Medical
  • Gloria Med
  • Zhende Medical Group
  • Maizi
  • TOKO
  • Okamoto Corporation
  • Zhejiang Sameri

Anti-Embolism Stockings Industry Research Segmentation

By Product:

  • Calf-length
  • Thigh-length

By Demography:

  • Men
  • Women

By End User:

  • Ambulatory Patients
  • Post-operative Patients
  • Pregnant Women
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)
Product Code: PMRREP33355

Table of Contents

1. Executive Summary

  • 1.1. Global Anti-Embolism Stockings Market Snapshot 2025 and 2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Industry Developments and Key Market Events
  • 1.5. Demand Side and Supply Side Analysis
  • 1.6. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definitions
  • 2.2. Value Chain Analysis
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global GDP Outlook
    • 2.3.2. Global Construction Industry Overview
    • 2.3.3. Global Mining Industry Overview
  • 2.4. Forecast Factors - Relevance and Impact
  • 2.5. COVID-19 Impact Assessment
  • 2.6. PESTLE Analysis
  • 2.7. Porter's Five Forces Analysis
  • 2.8. Geopolitical Tensions: Market Impact
  • 2.9. Regulatory and Technology Landscape

3. Market Dynamics

  • 3.1. Drivers
  • 3.2. Restraints
  • 3.3. Opportunities
  • 3.4. Trends

4. Price Trend Analysis, 2019-2032

  • 4.1. Region-wise Price Analysis
  • 4.2. Price by Segments
  • 4.3. Price Impact Factors

5. Global Anti-Embolism Stockings Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 5.1. Key Highlights
  • 5.2. Global Anti-Embolism Stockings Market Outlook: Product
    • 5.2.1. Introduction/Key Findings
    • 5.2.2. Historical Market Size (US$ Mn) Analysis by Product, 2019-2024
    • 5.2.3. Current Market Size (US$ Mn) Forecast, by Product, 2025-2032
      • 5.2.3.1. Calf-length
      • 5.2.3.2. Thigh-length
    • 5.2.4. Market Attractiveness Analysis: Product
  • 5.3. Global Anti-Embolism Stockings Market Outlook: Demography
    • 5.3.1. Introduction/Key Findings
    • 5.3.2. Historical Market Size (US$ Mn) Analysis by Demography, 2019-2024
    • 5.3.3. Current Market Size (US$ Mn) Forecast, by Demography, 2025-2032
      • 5.3.3.1. Men
      • 5.3.3.2. Women
    • 5.3.4. Market Attractiveness Analysis: Demography
  • 5.4. Global Anti-Embolism Stockings Market Outlook: End User
    • 5.4.1. Introduction/Key Findings
    • 5.4.2. Historical Market Size (US$ Mn) Analysis by End User, 2019-2024
    • 5.4.3. Current Market Size (US$ Mn) Forecast, by End User, 2025-2032
      • 5.4.3.1. Ambulatory Patients
      • 5.4.3.2. Post-operative Patients
      • 5.4.3.3. Pregnant Women
    • 5.4.4. Market Attractiveness Analysis: End User

6. Global Anti-Embolism Stockings Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Mn) Analysis by Region, 2019-2024
  • 6.3. Current Market Size (US$ Mn) Forecast, by Region, 2025-2032
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia & Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America Anti-Embolism Stockings Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 7.1. Key Highlights
  • 7.2. Pricing Analysis
  • 7.3. North America Market Size (US$ Mn) Forecast, by Country, 2025-2032
    • 7.3.1. U.S.
    • 7.3.2. Canada
  • 7.4. North America Market Size (US$ Mn) Forecast, by Product, 2025-2032
    • 7.4.1. Calf-length
    • 7.4.2. Thigh-length
  • 7.5. North America Market Size (US$ Mn) Forecast, by Demography, 2025-2032
    • 7.5.1. Men
    • 7.5.2. Women
  • 7.6. North America Market Size (US$ Mn) Forecast, by End User, 2025-2032
    • 7.6.1. Ambulatory Patients
    • 7.6.2. Post-operative Patients
    • 7.6.3. Pregnant Women

8. Europe Anti-Embolism Stockings Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Europe Market Size (US$ Mn) Forecast, by Country, 2025-2032
    • 8.3.1. Germany
    • 8.3.2. Italy
    • 8.3.3. France
    • 8.3.4. U.K.
    • 8.3.5. Spain
    • 8.3.6. Russia
    • 8.3.7. Rest of Europe
  • 8.4. Europe Market Size (US$ Mn) Forecast, by Product, 2025-2032
    • 8.4.1. Calf-length
    • 8.4.2. Thigh-length
  • 8.5. Europe Market Size (US$ Mn) Forecast, by Demography, 2025-2032
    • 8.5.1. Men
    • 8.5.2. Women
  • 8.6. Europe Market Size (US$ Mn) Forecast, by End User, 2025-2032
    • 8.6.1. Ambulatory Patients
    • 8.6.2. Post-operative Patients
    • 8.6.3. Pregnant Women

9. East Asia Anti-Embolism Stockings Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. East Asia Market Size (US$ Mn) Forecast, by Country, 2025-2032
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. South Korea
  • 9.4. East Asia Market Size (US$ Mn) Forecast, by Product, 2025-2032
    • 9.4.1. Calf-length
    • 9.4.2. Thigh-length
  • 9.5. East Asia Market Size (US$ Mn) Forecast, by Demography, 2025-2032
    • 9.5.1. Men
    • 9.5.2. Women
  • 9.6. East Asia Market Size (US$ Mn) Forecast, by End User, 2025-2032
    • 9.6.1. Ambulatory Patients
    • 9.6.2. Post-operative Patients
    • 9.6.3. Pregnant Women

10. South Asia & Oceania Anti-Embolism Stockings Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 10.1. Key Highlights
  • 10.2. Pricing Analysis
  • 10.3. South Asia & Oceania Market Size (US$ Mn) Forecast, by Country, 2025-2032
    • 10.3.1. India
    • 10.3.2. Southeast Asia
    • 10.3.3. ANZ
    • 10.3.4. Rest of SAO
  • 10.4. South Asia & Oceania Market Size (US$ Mn) Forecast, by Product, 2025-2032
    • 10.4.1. Calf-length
    • 10.4.2. Thigh-length
  • 10.5. South Asia & Oceania Market Size (US$ Mn) Forecast, by Demography, 2025-2032
    • 10.5.1. Men
    • 10.5.2. Women
  • 10.6. South Asia & Oceania Market Size (US$ Mn) Forecast, by End User, 2025-2032
    • 10.6.1. Ambulatory Patients
    • 10.6.2. Post-operative Patients
    • 10.6.3. Pregnant Women

11. Latin America Anti-Embolism Stockings Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 11.1. Key Highlights
  • 11.2. Pricing Analysis
  • 11.3. Latin America Market Size (US$ Mn) Forecast, by Country, 2025-2032
    • 11.3.1. Brazil
    • 11.3.2. Mexico
    • 11.3.3. Rest of LATAM
  • 11.4. Latin America Market Size (US$ Mn) Forecast, by Product, 2025-2032
    • 11.4.1. Calf-length
    • 11.4.2. Thigh-length
  • 11.5. Latin America Market Size (US$ Mn) Forecast, by Demography, 2025-2032
    • 11.5.1. Men
    • 11.5.2. Women
  • 11.6. Latin America Market Size (US$ Mn) Forecast, by End User, 2025-2032
    • 11.6.1. Ambulatory Patients
    • 11.6.2. Post-operative Patients
    • 11.6.3. Pregnant Women

12. Middle East & Africa Anti-Embolism Stockings Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 12.1. Key Highlights
  • 12.2. Pricing Analysis
  • 12.3. Middle East & Africa Market Size (US$ Mn) Forecast, by Country, 2025-2032
    • 12.3.1. GCC Countries
    • 12.3.2. South Africa
    • 12.3.3. Northern Africa
    • 12.3.4. Rest of MEA
  • 12.4. Middle East & Africa Market Size (US$ Mn) Forecast, by Product, 2025-2032
    • 12.4.1. Calf-length
    • 12.4.2. Thigh-length
  • 12.5. Middle East & Africa Market Size (US$ Mn) Forecast, by Demography, 2025-2032
    • 12.5.1. Men
    • 12.5.2. Women
  • 12.6. Middle East & Africa Market Size (US$ Mn) Forecast, by End User, 2025-2032
    • 12.6.1. Ambulatory Patients
    • 12.6.2. Post-operative Patients
    • 12.6.3. Pregnant Women

13. Competition Landscape

  • 13.1. Market Share Analysis, 2024
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles
    • 13.3.1. MD
      • 13.3.1.1. Company Overview
      • 13.3.1.2. Product Portfolio/Offerings
      • 13.3.1.3. Key Financials
      • 13.3.1.4. SWOT Analysis
      • 13.3.1.5. Company Strategy and Key Developments
    • 13.3.2. Medtronic(Covidien)
    • 13.3.3. Sigvaris, Medi
    • 13.3.4. BSN Medical
    • 13.3.5. Juzo
    • 13.3.6. 3M
    • 13.3.7. Bauerfeind AG
    • 13.3.8. Thuasne Corporate
    • 13.3.9. Pretty Legs Hosiery
    • 13.3.10. Salzmann-Group
    • 13.3.11. Paul Hartmann
    • 13.3.12. Cizeta Medicali
    • 13.3.13. Belsana Medical
    • 13.3.14. Gloria Med
    • 13.3.15. Zhende Medical Group

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!